The comparison between SS patients and the healthy control group showed that the serum IL-22 level of SS patients was significantly increased, and the serum IL-22 level was significantly positively correlated with anti-SSA, anti-SSB, and rheumatoid factor (RF) (74). This evidence concerns the gene IL22 and synovial sarcoma.